Atlas Trials

NOrth American Study for the Treatment of Recurrent epIstaxis With DoxycycLine: The NOSTRIL Trial

Clinical trial NCT04167085 · COMPLETED

Trial details

NCT number
NCT04167085
Sponsor
University of California, Los Angeles
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Epistaxis
Start date
2017-12-18
Primary completion
2021-06-01
Enrollment
26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.